Jennifer Bath

Jennifer Bath is the founder of IPA (ImmunoPrecise Antibodies). IPA (ImmunoPrecise Antibodies) has raised $200M in total funding.

About Jennifer Bath

Dr. Jennifer Bath is the CEO and President of ImmunoPrecise Antibodies (IPA), a global leader in therapeutic antibody discovery and development. She has raised more than $200 million in capital and managed acquisitions across her career. Bath is also a co-founder of IPA and serves on its board of directors.

Jennifer Bath at a glance

More founders in Victoria, BC, Canada (44)

Browse related founder lists (2)

Full founder directory · Investor directory · Company funding database · Fundraising library